"Designing Growth Strategies is in our DNA"

Precision Medicine Market Size, Share & Industry Analysis, By Product (Drugs, Devices, Software), By Type (Diagnostic {Genetic Tests [Predictive & Presymptomatic Tests, Carrier Testing, Prenatal & Newborn Screening], Biomarker Tests [Screening, Recurrence Monitoring, & Therapy Selection]}, Therapeutics {Monoclonal Antibodies, Gene Therapy, Cell Therapy}, & Research), By Indication (Oncology, Neurology/ Psychiatry, Immunology), By End-User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations), & Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI110463

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Estimated Year

2024

Base Year

2023

Forecast Period

2024-2032

Historical Period

2019-2022

Unit

Value (USD Billion)

Growth Rate

CAGR of 10.8% from 2024-2032

 

 

 

 

 

 Segmentation

 

By Product

  • Drugs
  • Devices
  • Software

By Type

  • Diagnostic
    • Genetic Tests
      • Predictive & Presymptomatic Tests
      • Carrier Testing
      • Prenatal & Newborn Screening
      • Others
    • Biomarker Tests
      • Screening
      • Recurrence Monitoring
      • Therapy Selection
    • Others
  • Therapeutics
    • Monoclonal Antibodies
    • Gene Therapy
    • Cell Therapy
    • Others
  • Research

By Indication

  • Oncology
  • Neurology/ Psychiatry
  • Immunology
  • Cardiology
  • Endocrinology
  • Others

By End-User

  • Pharmaceutical & Biopharmaceutical Companies
  • Diagnostic Laboratories
  • Contract Research Organizations (CROs)
  • Others

By Region

  • North America (By Product, By Type, Indication, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Product, By Type, Indication, End-User, and Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, By Type, Indication, End-User, and Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, By Type, Indication, End-User, and Country/Sub-Region)
    • Brazil
    • Mexico
    •  Rest of Latin America
  • Middle East & Africa (By Product, By Type, Indication, End-User and Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

 

  • 2019-2032
  • 2023
  • 2019-2022
  • 181
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann